| Title : Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition - Seitz_2009_Anticancer.Drugs_20_553 |
| Author(s) : Seitz S , Schally AV , Treszl A , Papadia A , Rick F , Szalontay L , Szepeshazi K , Ortmann O , Halmos G , Hohla F , Buchholz S |
| Ref : Anticancer Drugs , 20 :553 , 2009 |
| Abstract : Seitz_2009_Anticancer.Drugs_20_553 |
| ESTHER : Seitz_2009_Anticancer.Drugs_20_553 |
| PubMedSearch : Seitz_2009_Anticancer.Drugs_20_553 |
| PubMedID: 19491659 |
| Title : Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies - Nagy_2000_Proc.Natl.Acad.Sci.U.S.A_97_829 |
| Author(s) : Nagy A , Plonowski A , Schally AV |
| Ref : Proceedings of the National Academy of Sciences of the United States of America , 97 :829 , 2000 |
| Abstract : Nagy_2000_Proc.Natl.Acad.Sci.U.S.A_97_829 |
| ESTHER : Nagy_2000_Proc.Natl.Acad.Sci.U.S.A_97_829 |
| PubMedSearch : Nagy_2000_Proc.Natl.Acad.Sci.U.S.A_97_829 |
| PubMedID: 10639165 |